|
Melvin D. Booth, Chairman. Melvin D. Booth was a director of MedImmune, Inc. from November 1998 until March 2005 and served as its president and chief operating officer from October 1998 through December 2003. Prior to joining MedImmune, Inc., Mr. Booth was president, chief operating officer, and a member of the board of directors of Human Genome Sciences, Inc. from July 1995 to October 1998. Mr. Booth held many executive positions from 1975 to July 1995 at Syntex, including president of Syntex’s US pharmaceutical business. Mr. Booth is currently a board member of Millipore Corporation and Ventria Bioscience. Mr. Booth also currently serves as chairman of the board of directors for Prestwick Pharmaceuticals, Inc. and as a member of the Strategic Advisory Committee of Genstar Capital, L.P. Mr. Booth graduated with honors and holds an honorary Doctor of Science degree from Northwest Missouri State University. He is a Certified Public Accountant. Mr. Booth currently serves as chairman of our audit committee and became chairman of our board of directors in December 2006. | 